Heart Failure-USB: Prediction and Progression
Launched by UNIVERSITY HOSPITAL, BASEL, SWITZERLAND · Jun 25, 2019
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
The Heart Failure-USB trial is a research study aimed at understanding what causes heart failure and how it gets worse over time. Researchers will look at patients who were hospitalized between 2010 and 2023 for serious heart issues, specifically acute coronary syndrome (a type of heart attack) and acute heart failure. The study will help identify which patients are at higher risk for developing heart failure and predict how their condition might change. Additionally, a smaller part of the study will examine the safety and effectiveness of a medication called digoxin for patients with heart failure caused by a fast heart rate.
To participate in this study, you need to be someone who was hospitalized with a primary diagnosis of acute coronary syndrome or with acute heart failure. Unfortunately, if you have previously stated that you do not want your medical information used for research, you would not be eligible to participate. If you join, you can expect to contribute to important research that could help improve the understanding and treatment of heart failure for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients hospitalized with a primary diagnosis of ACS
- • Patients hospitalized with a primary or secondary diagnosis of AHF
- Exclusion Criteria:
- • Existence of a documented statement of the patient against the scientific use of clinical data
About University Hospital, Basel, Switzerland
The University Hospital Basel, Switzerland, is a leading academic medical center renowned for its commitment to cutting-edge research and innovative patient care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise and state-of-the-art facilities to advance medical knowledge and therapeutic options across various disciplines. With a collaborative approach that integrates clinical practice and scientific inquiry, the University Hospital Basel fosters an environment conducive to rigorous clinical trials, ensuring the highest standards of safety and efficacy. Its strategic focus on patient-centered research aims to translate scientific discoveries into tangible health solutions, benefiting both local and global communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Basel, , Switzerland
Patients applied
Trial Officials
Christian Müller, Prof. Dr.
Principal Investigator
Cardiology University Hospital Basel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials